These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1676847)

  • 1. Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination.
    Schechter MD
    Pharmacol Biochem Behav; 1991 Mar; 38(3):539-44. PubMed ID: 1676847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDMA as a discriminative stimulus: isomeric comparisons.
    Schechter MD
    Pharmacol Biochem Behav; 1987 May; 27(1):41-4. PubMed ID: 2886996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and developmental effects of two 3,4-methylenedioxymethamphetamine (MDMA) derivatives.
    Bronson ME; Barrios-Zambrano L; Jiang W; Clark CR; DeRuiter J; Newland MC
    Drug Alcohol Depend; 1994 Dec; 36(3):161-6. PubMed ID: 7889806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    Schechter MD
    Pharmacol Biochem Behav; 1988 Dec; 31(4):817-24. PubMed ID: 2908067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative profile of MDMA.
    Schechter MD
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1533-7. PubMed ID: 2874566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical basis of neurotoxicity.
    Gibb JW; Johnson M; Hanson GR
    Neurotoxicology; 1990; 11(2):317-21. PubMed ID: 1978271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic-dopaminergic mediation of MDMA's discriminative stimulus effects in a three-choice discrimination.
    Goodwin AK; Pynnonen DM; Baker LE
    Pharmacol Biochem Behav; 2003 Mar; 74(4):987-95. PubMed ID: 12667914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxicity of MDMA: neurochemical effects.
    Schmidt CJ; Kehne JH
    Ann N Y Acad Sci; 1990; 600():665-80; discussion 680-1. PubMed ID: 1979217
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity.
    Grob C; Bravo G; Walsh R
    Arch Gen Psychiatry; 1990 Mar; 47(3):288-9. PubMed ID: 1968330
    [No Abstract]   [Full Text] [Related]  

  • 11. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI; Green AR
    Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents.
    Gatch MB; Dolan SB; Forster MJ
    Behav Pharmacol; 2016 Sep; 27(6):497-505. PubMed ID: 27028902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat.
    Hekmatpanah CR; McKenna DJ; Peroutka SJ
    Neurosci Lett; 1989 Sep; 104(1-2):178-82. PubMed ID: 2573011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity.
    Brodkin J; Malyala A; Nash JF
    Pharmacol Biochem Behav; 1993 Jul; 45(3):647-53. PubMed ID: 8101380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
    Oberlender R; Nichols DE
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1098-106. PubMed ID: 1979813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
    Battaglia G; Yeh SY; De Souza EB
    Pharmacol Biochem Behav; 1988 Feb; 29(2):269-74. PubMed ID: 2452449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantages and disadvantages of a rapid method to train drug discrimination.
    Schechter MD
    Pharmacol Biochem Behav; 1988 Sep; 31(1):239-42. PubMed ID: 2908064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons.
    Evans SM; Johanson CE
    Drug Alcohol Depend; 1986 Oct; 18(2):159-64. PubMed ID: 2877843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxic effect of MDMA on brain serotonin neurons: evidence from neurochemical and radioligand binding studies.
    De Souza EB; Battaglia G; Insel TR
    Ann N Y Acad Sci; 1990; 600():682-97; discussion 697-8. PubMed ID: 1979218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats.
    St Omer VE; Ali SF; Holson RR; Duhart HM; Scalzo FM; Slikker W
    Neurotoxicol Teratol; 1991; 13(1):13-20. PubMed ID: 1710762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.